We propose to examine biological fluids from cells treated with individual drugs that have been approved previously by the U.S. Food and Drug Administration for the treatment of numerous diseases and disorders. We will determine whether these drugs reduce the levels of the toxic proteins known to cause Alzheimer’s disease. Newly identified drugs or similar modified compounds will be developed as Alzheimer’s therapeutics.
Drug Discovery, Drug Screening Projects
Weiming Xia, Ph.D.
Mehdi Jorfi, Joseph Park, Rudy Tanzi, | 2021
Weiming Xia, | 2021
Stephen T.C. Wong, | 2021
Hermann Steller, | 2021
Doo Yeon Kim, Luisa Quinti, | 2021
Seiko Ikezu, Tsuneya Ikezu, | 2021
Ana Griciuc, | 2021
Li Gan, Subhash Sinha, | 2021